Correlation Between Neurobo Pharmaceuticals and Pasithea Therapeutics
Can any of the company-specific risk be diversified away by investing in both Neurobo Pharmaceuticals and Pasithea Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurobo Pharmaceuticals and Pasithea Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurobo Pharmaceuticals and Pasithea Therapeutics Corp, you can compare the effects of market volatilities on Neurobo Pharmaceuticals and Pasithea Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurobo Pharmaceuticals with a short position of Pasithea Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurobo Pharmaceuticals and Pasithea Therapeutics.
Diversification Opportunities for Neurobo Pharmaceuticals and Pasithea Therapeutics
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Neurobo and Pasithea is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Neurobo Pharmaceuticals and Pasithea Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pasithea Therapeutics and Neurobo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurobo Pharmaceuticals are associated (or correlated) with Pasithea Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pasithea Therapeutics has no effect on the direction of Neurobo Pharmaceuticals i.e., Neurobo Pharmaceuticals and Pasithea Therapeutics go up and down completely randomly.
Pair Corralation between Neurobo Pharmaceuticals and Pasithea Therapeutics
Given the investment horizon of 90 days Neurobo Pharmaceuticals is expected to generate 0.96 times more return on investment than Pasithea Therapeutics. However, Neurobo Pharmaceuticals is 1.04 times less risky than Pasithea Therapeutics. It trades about -0.02 of its potential returns per unit of risk. Pasithea Therapeutics Corp is currently generating about -0.03 per unit of risk. If you would invest 1,136 in Neurobo Pharmaceuticals on August 27, 2024 and sell it today you would lose (899.00) from holding Neurobo Pharmaceuticals or give up 79.14% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 99.8% |
| Values | Daily Returns |
Neurobo Pharmaceuticals vs. Pasithea Therapeutics Corp
Performance |
| Timeline |
| Neurobo Pharmaceuticals |
| Pasithea Therapeutics |
Neurobo Pharmaceuticals and Pasithea Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neurobo Pharmaceuticals and Pasithea Therapeutics
The main advantage of trading using opposite Neurobo Pharmaceuticals and Pasithea Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurobo Pharmaceuticals position performs unexpectedly, Pasithea Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pasithea Therapeutics will offset losses from the drop in Pasithea Therapeutics' long position.| Neurobo Pharmaceuticals vs. Allarity Therapeutics | Neurobo Pharmaceuticals vs. Virax Biolabs Group | Neurobo Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Neurobo Pharmaceuticals vs. Biodexa Pharmaceticals |
| Pasithea Therapeutics vs. Nutriband Warrant | Pasithea Therapeutics vs. MediciNova | Pasithea Therapeutics vs. Eliem Therapeutics | Pasithea Therapeutics vs. Virax Biolabs Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |